Seelaus Asset Management’s Pfizer PFE Stock Holding History

Seelaus Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$249K	Sell	10,345 -1,125	-10%	-$29.4K	0.17%	165
2026 Q1	$318K	Buy	+11,470	New	+$305K	0.23%	127
2025 Q3	–	Sell	-8,400	Closed	-$204K	–	189
2025 Q2	$204K	Sell	8,400 -14,442	-63%	-$337K	0.18%	158
2025 Q1	$579K	Sell	22,842 -2,565	-10%	-$67.1K	0.55%	54
2024 Q4	$674K	Sell	25,407 -4,020	-14%	-$109K	0.61%	43
2024 Q3	$852K	Buy	29,427 +11,215	+62%	+$327K	0.78%	32
2024 Q2	$510K	Buy	18,212 +3,227	+22%	+$88.8K	0.52%	58
2024 Q1	$416K	Sell	14,985 -3,051	-17%	-$84.7K	0.41%	83
2023 Q4	$519K	Buy	18,036 +3,508	+24%	+$106K	0.5%	66
2023 Q3	$482K	Sell	14,528 -4,561	-24%	-$161K	0.55%	58
2023 Q2	$700K	Sell	19,089 -2,720	-12%	-$106K	0.55%	60
2023 Q1	$884K	Buy	21,809 +14,580	+202%	+$630K	0.67%	40
2022 Q4	$370K	Buy	7,229 +1	+0%	+$48	0.28%	118
2022 Q3	$316K	Sell	7,228 -73	-1%	-$3.55K	0.25%	130
2022 Q2	$383K	Buy	7,301 +77	+1%	+$3.92K	0.28%	112
2022 Q1	$374K	Sell	7,224 -493	-6%	-$25.6K	0.22%	144
2021 Q4	$456K	Sell	7,717 -1,349	-15%	-$66.8K	0.25%	120
2021 Q3	$390K	Buy	9,066 +1	+0%	+$44	0.23%	142
2021 Q2	$355K	Buy	9,065 +127	+1%	+$4.94K	0.21%	165
2021 Q1	$324K	Sell	8,938 -1,196	-12%	-$42.5K	0.21%	146
2020 Q4	$373K	Sell	10,134 -6,540	-39%	-$240K	0.27%	106
2020 Q3	$581K	Buy	16,674 +3,706	+29%	+$130K	0.47%	65
2020 Q2	$402K	Buy	12,968 +333	+3%	+$11.3K	0.37%	88
2020 Q1	$391K	Hold	12,635	–	–	0.46%	65
2019 Q4	$470K	Buy	12,635 +3,131	+33%	+$112K	0.38%	83
2019 Q3	$324K	Buy	9,504 +1,024	+12%	+$37.2K	0.28%	97
2019 Q2	$349K	Sell	8,480 -19,803	-70%	-$786K	0.32%	88
2019 Q1	$1.14M	Sell	28,283 -11,475	-29%	-$460K	1.06%	26
2018 Q4	$1.65M	Buy	39,758 +8,081	+26%	+$335K	1.76%	8
2018 Q3	$1.32M	Buy	31,677 +13	+0%	+$500	1.09%	21
2018 Q2	$1.09M	Sell	31,664 -6,959	-18%	-$238K	0.95%	38
2018 Q1	$1.3M	Buy	38,623 +7,203	+23%	+$248K	1.12%	22
2017 Q4	$1.08M	Buy	+31,420	New	+$1.07M	0.94%	34

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Seelaus Asset Management's PFE Position: Q2 2026 in Review

Seelaus Asset Management reduced its Pfizer (PFE) stake by 9.8% in Q2 2026, selling an estimated $29.4K and leaving 10,345 shares worth $249K. The position accounts for 0.17% of the portfolio, ranked #165.

Seelaus Asset Management first reported a position in PFE in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.65M in Q4 2018. 1,237 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Seelaus Asset Management held 10,345 shares of Pfizer worth $249K as of Q2 2026.
Seelaus Asset Management sold 1,125 Pfizer shares in Q2 2026, an estimated $29.4K.
Pfizer made up 0.17% of Seelaus Asset Management's portfolio in Q2 2026, its #165 holding.
Seelaus Asset Management first reported a position in Pfizer in Q4 2017 and has held it in 33 quarters since.
Seelaus Asset Management's Pfizer position peaked at $1.65M in Q4 2018.
1,237 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Seelaus Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.